Somnomed Ltd
ASX:SOM
Somnomed Ltd
ASX:SOM
Price:
0.21 AUD
Market Closed
Updated:
Apr 28, 2024
Somnomed Ltd
Operating Income
|
Somnomed Ltd
Operating Income Peer Comparison
Comparables:
NTI
IPD
C
CYC
COH
EMV
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Operating Income
-AU$6.5m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Neurotech International Ltd
ASX:NTI
|
Operating Income
-AU$7.8m
|
CAGR 3-Years
-82%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Operating Income
-AU$20.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-12%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Operating Income
-AU$8.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-119%
|
CAGR 10-Years
-25%
|
|
|
Cochlear Ltd
ASX:COH
|
Operating Income
AU$491.1m
|
CAGR 3-Years
36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Operating Income
-AU$3.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Operating Income?
Operating Income
-6.5m
AUD
-6.5m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Operating Income amounts to -6.5m AUD.
What is Somnomed Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-9%
-9%
Over the last year, the Operating Income growth was -81%. The average annual Operating Income growth rates for Somnomed Ltd have been -58% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
